Phase II study of atezolizumab with bevacizumab for non-squamous non-small cell lung cancer with high PD-L1 expression (@Be Study).

Takashi SetoKaname NosakiMototsugu ShimokawaRyo ToyozawaShunichi SugawaraHidetoshi HayashiHaruyasu MurakamiTerufumi KatoSeiji NihoHideo SakaMasahide OkiHiroshige YoshiokaIsamu OkamotoHaruko DagaKoichi AzumaHiroshi TanakaKazumi NishinoRie TohnaiNobuyuki YamamotoKazuhiko Nakagawa

Published in: Journal for immunotherapy of cancer (2022)

JapicCTI-184038.

Keyphrases

phase ii study
open label
locally advanced
randomized controlled trial
squamous cell carcinoma
low grade
clinical trial
radiation therapy
placebo controlled
double blind